HD LifeSciences Launches New Implant Footprints at State of Spine Surgery Meeting


HD Lifesciences launched 3 new implant footprints at the State of Spine Surgery Meeting in Aruba last month, including a Hyperlordotic TLIF, Hyperlordotic ALIF, and Curved TLIF. This expands the Soft Titanium® portfolio to 14 product lines and accommodates a variety of surgeon preferences and patient anatomies for PLIF, TLIF, ALIF, or ACDF procedures.

HD Lifesciences’ Soft Titanium® structural lattice has been implanted over 1,650 times since its introduction in summer of 2017. Over 500 have been Hive™ TLIFs with the insert-and-rotate technique. Over the next 24 months, HD plans to publish multiple clinical and experimental studies to demonstrate the biological and biomechanical advantages of Soft Titanium®.

About HD LifeSciences

HD Lifesciences is transforming orthopedic care with our Hive™ Soft Titanium® technology. The Hive™ lattice design provides ideal elastic modulus, diagnostic imaging, and osteogenic properties. Founded with a mission to improve surgical methods and devices, HD LifeSciences brings together science and engineering to improve patient care.

Print Friendly, PDF & Email

Chris J. Stewart

Chris currently serves as Chief Executive Officer of Surgio Health as well as Chief Operating Officer at Ortho Spine Partners. Prior to that, he was the assistant vice president and business unit leader of Medical Device Management for HealthTrust Purchasing Group (HPG).

Related Articles

Back to top button